1. Montefusco E, Monarca B, Tribalto M. Coexistent idiopathic thrombocythaemia and monoclonal component: a causal association? Scand J Haematol. 1985; 35:584. PMID:
4089537.
Article
2. Kyrtsonis MC, Kokoris SI, Kontopidou FN, Siakantaris MP, Kittas C, Pangalis GA. Development of a myeloproliferative disorder in a patient with monoclonal gammopathy of undetermined significance secreting immunoglobulin of the M class and treated with thalidomide and anti-CD20 monoclonal antibody. Blood. 2001; 97:2527–2528. PMID:
11307775.
Article
3. Tosato F, Fossaluzza V, Rossi P, et al. Monoclonal gammopathy of undetermined significance in a case of primary thrombocythemia. Haematologica. 1986; 71:417–418. PMID:
3096839.
4. Prosper F, Borbolla JR, Rifon J, et al. Coexistence of essential thrombocythemia and multiple myeloma. Ann Hematol. 1992; 65:103–105. PMID:
1511057.
Article
5. Majhail NS, Lichtin AE. Rare coexistence of multiple myeloma with essential thrombocythemia: report of two cases. Haematologica. 2003; 88:ECR09. PMID:
12681982.
6. Kuroda J, Matsumoto Y, Tanaka R, et al. JAK2V617F-positive essential thrombocythemia and multiple myeloma with IGH/CCND1 gene translocation coexist, but originate from separate clones. Acta Haematol. 2008; 120:177–181. PMID:
19129688.
Article
7. Holtan SG, Hoyer JD, Buadi FK. Multiple myeloma with concomitant JAK2-positive essential thrombocythemia post-successful autologous peripheral blood hematopoietic stem cell transplant. Bone Marrow Transplant. 2011; 46:615. PMID:
20581888.
Article
8. Eskazan AE, Ongoren S, Ar MC, et al. Essential thrombocythemia and multiple myeloma: two rare diseases in one patient. Clin Lymphoma Myeloma Leuk. 2011; 11:442–445. PMID:
21859555.
Article
9. Dispenzieri A. How I treat POEMS syndrome. Blood. 2012; 119:5650–5658. PMID:
22547581.
Article